BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 11454665)

  • 1. Inhibition of poly (ADP-ribose) synthetase by gene disruption or inhibition with 5-iodo-6-amino-1,2-benzopyrone protects mice from multiple-low-dose-streptozotocin-induced diabetes.
    Mabley JG; Suarez-Pinzon WL; Haskó G; Salzman AL; Rabinovitch A; Kun E; Szabó C
    Br J Pharmacol; 2001 Jul; 133(6):909-19. PubMed ID: 11454665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combined inducible nitric oxide synthase inhibitor and free radical scavenger guanidinoethyldisulfide prevents multiple low-dose streptozotocin-induced diabetes in vivo and interleukin-1beta-induced suppression of islet insulin secretion in vitro.
    Mabley JG; Southan GJ; Salzman AL; Szabó C
    Pancreas; 2004 Mar; 28(2):E39-44. PubMed ID: 15028959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin prevents streptozotocin-induced islet damage by scavenging free radicals: a prophylactic and protective role.
    Meghana K; Sanjeev G; Ramesh B
    Eur J Pharmacol; 2007 Dec; 577(1-3):183-91. PubMed ID: 17900558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes.
    Flodström M; Tyrberg B; Eizirik DL; Sandler S
    Diabetes; 1999 Apr; 48(4):706-13. PubMed ID: 10102685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin protects against streptozotocin, but not interleukin-1beta-induced damage of rodent pancreatic beta-cells.
    Andersson AK; Sandler S
    J Pineal Res; 2001 Apr; 30(3):157-65. PubMed ID: 11316326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
    Sternesjö J; Welsh N; Sandler S
    Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of 1400 W, a novel inhibitor of inducible nitric oxide synthase, in preventing interleukin-1beta-induced suppression of pancreatic islet function in vitro and multiple low-dose streptozotocin-induced diabetes in vivo.
    Rydgren T; Sandler S
    Eur J Endocrinol; 2002 Oct; 147(4):543-51. PubMed ID: 12370118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, against streptozotocin-induced diabetes.
    Masiello P; Cubeddu TL; Frosina G; Bergamini E
    Diabetologia; 1985 Sep; 28(9):683-6. PubMed ID: 2933287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of 5-iodo-6-amino-1,2-benzopyrone, an inhibitor of poly(ADP-ribose) synthetase against peroxynitrite-induced glial damage and stroke development.
    Endres M; Scott GS; Salzman AL; Kun E; Moskowitz MA; Szabó C
    Eur J Pharmacol; 1998 Jun; 351(3):377-82. PubMed ID: 9721031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin secretion, DNA damage, and apoptosis in human and rat islets of Langerhans following exposure to nitric oxide, peroxynitrite, and cytokines.
    Hadjivassiliou V; Green MH; James RF; Swift SM; Clayton HA; Green IC
    Nitric Oxide; 1998; 2(6):429-41. PubMed ID: 10342486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxynitrite-induced thymocyte apoptosis: the role of caspases and poly (ADP-ribose) synthetase (PARS) activation.
    Virág L; Scott GS; Cuzzocrea S; Marmer D; Salzman AL; Szabó C
    Immunology; 1998 Jul; 94(3):345-55. PubMed ID: 9767416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effect of Flos magnoliae extract on multiple low dose streptozotocin-induced type 1 diabetes development and cytokine-induced beta-cell damage.
    Kim EK; Song MY; Kim IS; Moon WS; Ryu DG; So HS; Park R; Park JW; Kwon KB; Park BH
    Int J Mol Med; 2008 Oct; 22(4):481-8. PubMed ID: 18813855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents.
    Jagtap P; Soriano FG; Virág L; Liaudet L; Mabley J; Szabó E; Haskó G; Marton A; Lorigados CB; Gallyas F; Sümegi B; Hoyt DG; Baloglu E; VanDuzer J; Salzman AL; Southan GJ; Szabó C
    Crit Care Med; 2002 May; 30(5):1071-82. PubMed ID: 12006805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel role of curcumin in the prevention of cytokine-induced islet death in vitro and diabetogenesis in vivo.
    Kanitkar M; Gokhale K; Galande S; Bhonde RR
    Br J Pharmacol; 2008 Nov; 155(5):702-13. PubMed ID: 18695642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicorandil improves diabetes and rat islet beta-cell damage induced by streptozotocin in vivo and in vitro.
    Kasono K; Yasu T; Kakehashi A; Kinoshita N; Tamemoto H; Namai K; Ohno R; Ueba H; Kuroki M; Ishikawa S; Kawakami M
    Eur J Endocrinol; 2004 Aug; 151(2):277-85. PubMed ID: 15296485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(ADP-ribose) polymerase 1 inhibition protects cardiomyocytes from inflammation and apoptosis in diabetic cardiomyopathy.
    Qin WD; Liu GL; Wang J; Wang H; Zhang JN; Zhang F; Ma Y; Ji XY; Li C; Zhang MX
    Oncotarget; 2016 Jun; 7(24):35618-35631. PubMed ID: 27027354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection by thymidine, an inhibitor of polyadenosine diphosphate ribosylation, of streptozotocin inhibition of insulin secretion.
    Bolaffi JL; Nagamatsu S; Harris J; Grodsky GM
    Endocrinology; 1987 May; 120(5):2117-22. PubMed ID: 2952491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA strand breaks and poly(ADP-ribose) synthetase activation in pancreatic islets--a new aspect to development of insulin-dependent diabetes and pancreatic B-cell tumors.
    Okamoto H; Yamamoto H
    Princess Takamatsu Symp; 1983; 13():297-308. PubMed ID: 6317640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(ADP-ribose) polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes.
    Masutani M; Suzuki H; Kamada N; Watanabe M; Ueda O; Nozaki T; Jishage K; Watanabe T; Sugimoto T; Nakagama H; Ochiya T; Sugimura T
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2301-4. PubMed ID: 10051636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to type 1 diabetes induction in 12-lipoxygenase knockout mice.
    Bleich D; Chen S; Zipser B; Sun D; Funk CD; Nadler JL
    J Clin Invest; 1999 May; 103(10):1431-6. PubMed ID: 10330425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.